Whittier Trust CO Gilead Sciences, Inc. Transaction History

Whittier Trust CO

$7.37 Billion
Q3 2024

A detailed history of Whittier Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Whittier Trust CO holds 40,518 shares of GILD stock, worth $3.64 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

40,518

Previous 43,352 6.54%

Holding current value

$3.64 Million

Previous $2.97 Million 14.19%

% of portfolio

0.05%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$66.59 - $83.99 $188,716 - $238,027	-2,834 Reduced 6.54%	40,518 $3.4 Million
Q2 2024 Jul 26, 2024	SELL	$63.15 - $72.88 $104,829 - $120,980	-1,660 Reduced 3.69%	43,352 $2.97 Million
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $207,510 - $253,053	-2,899 Reduced 6.05%	45,012 $3.3 Million
Q4 2023 Jan 11, 2024	SELL	$73.27 - $83.09 $243,842 - $276,523	-3,328 Reduced 6.5%	47,911 $3.88 Million
Q3 2023 Oct 27, 2023	SELL	$73.94 - $80.67 $46,877 - $51,144	-634 Reduced 1.22%	51,239 $3.84 Million
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $76,010 - $86,700	-1,000 Reduced 1.89%	51,873 $4 Million
Q1 2023 Apr 21, 2023	SELL	$77.31 - $88.08 $363,202 - $413,799	-4,698 Reduced 8.16%	52,873 $4.39 Million
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $661,464 - $949,634	-10,614 Reduced 15.57%	57,571 $0
Q3 2022 Oct 21, 2022	SELL	$59.54 - $68.01 $339,735 - $388,065	-5,706 Reduced 7.72%	68,185 $4.21 Million
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $802,365 - $903,704	-13,901 Reduced 15.83%	73,891 $4.57 Million
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $4.35 Million - $5.46 Million	-75,181 Reduced 46.13%	87,792 $5.22 Million
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $44,896 - $50,958	692 Added 0.43%	162,973 $11.8 Million
Q3 2021 Nov 01, 2021	BUY	$67.69 - $73.03 $174,098 - $187,833	2,572 Added 1.61%	162,281 $11.3 Million
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $217,955 - $238,147	3,434 Added 2.2%	159,709 $11 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $208,260 - $237,624	3,471 Added 2.27%	156,275 $10.1 Million
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $716,735 - $816,686	-12,652 Reduced 7.65%	152,804 $8.9 Million
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $509,220 - $640,256	8,200 Added 5.21%	165,456 $10.5 Million
Q2 2020 Jul 10, 2020	SELL	$72.34 - $84.0 $1.2 Million - $1.39 Million	-16,536 Reduced 9.51%	157,256 $12.1 Million
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $423,879 - $542,928	-6,768 Reduced 3.75%	173,792 $13 Million
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $277,474 - $305,213	-4,503 Reduced 2.43%	180,560 $11.7 Million
Q3 2019 Oct 18, 2019	BUY	$62.51 - $69.0 $294,422 - $324,990	4,710 Added 2.61%	185,063 $11.7 Million
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $70,036 - $78,538	1,132 Added 0.63%	180,353 $12.2 Million
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $246,368 - $275,997	3,940 Added 2.25%	179,221 $11.7 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $260,382 - $339,779	-4,301 Reduced 2.4%	175,281 $11 Million
Q3 2018 Oct 23, 2018	BUY	$71.28 - $78.92 $201,294 - $222,870	2,824 Added 1.6%	179,582 $13.9 Million
Q2 2018 Jul 27, 2018	BUY	$64.88 - $75.68 $1.66 Million - $1.94 Million	25,598 Added 16.93%	176,758 $12.5 Million
Q2 2018 Jul 20, 2018	SELL	$64.88 - $75.68 $1.8 Million - $2.1 Million	-27,752 Reduced 15.51%	151,160 $12.5 Million
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $765,402 - $933,110	10,508 Added 6.24%	178,912 $13.5 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $113,199 - $132,880	-1,591 Reduced 0.94%	168,404 $12.1 Million
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $12.3 Million - $14.5 Million	169,995	169,995 $13.8 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Account

Whittier Trust CO Gilead Sciences, Inc. Transaction History